Assesment of New Devices for the Diagnostic Evaluation of Diaphragmatic Dysfunction (DYSDIA)

this study aim to evaluate wether new, non-invasive and non-contact devices such as Structured Light Plethysmography (SLP) and Sonar would be able to accurately detect and quantify diaphragm dysfunction (mono-or-bilateral) by assessing the asymmetric chest wall motion generated during spontaneous breathing as compared with a classic, standard and invasive technique.

Study Overview

Detailed Description

The measurements of chest and abdominal wall movements during quiet tidal breathing will be performed simultaneously using SLP and Sonar devices.

Subjects will be asked to sit down on a chair with their neck in a neutral position and their back as straight as possible. The SLP and the Sonar will be lined up to project the grid of light and the ultrasonic wave sonar over the participant's chest and abdomen. Data will be collected during 5 minutes of tidal breathing. The same procedure will be repeated while having the patient lying down in supine position on the same chair for 5 additional minutes. During both sessions (sitting and supine), patients will be asked to perform a gentle inspiratory capacity (IC) maneuver to better appreciate the thoraco-abdominal asymmetry and distortion.

Study Type

Observational

Enrollment (Actual)

125

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75013
        • INSERM-UPC UMR_S 1158 Service de Pneumologie et Réanimation, R3S, Groupe Hospitalier Pitié-Salpêtrière

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Patients with a suspicion of diaphragmatic dysfunction and healthy volunteers without any medical condition.

Description

FOR HEALTHY VOLUNTEERS

Inclusion Criteria:

  • no respiratory disease
  • no neurologic disease
  • no thoracic deformation

Exclusion criteria

  • respiratory disease
  • neurologic disease
  • thoracic deformation

FOR PATIENTS

Inclusion Criteria:

  • patients with a suspicion of diaphragmatic dysfunction

Exclusion Criteria:

  • pregnant women
  • contraindications to standard procedure requiring transdiaphragmatic measurement

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients
Patients with a suspicion of diaphragmatic dysfunction
Measurements of chest wall and abdominal wall movement will be performed while subjects are breathing quietly
Measurements of chest wall and abdominal wall movement will be performed while subjects are breathing quietly
Healthy volunteers
Subjects without any medical condition
Measurements of chest wall and abdominal wall movement will be performed while subjects are breathing quietly
Measurements of chest wall and abdominal wall movement will be performed while subjects are breathing quietly

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
amplitude of displacement of thoraco-abdominal compartments
Time Frame: 10 minutes
asymmetry of displacement of thoraco-abdominal compartments during tidal breathing and respiratory manoeuvres
10 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
displacement speed of thoraco-abdominal compartments
Time Frame: 10 minutes
asynchrony of displacement of thoraco-abdominal compartments during tidal breathing and respiratory manoeuvres measurement
10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pierantonio LAVENEZIANA, MD, PhD, UMRS_1158

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 11, 2018

Primary Completion (Actual)

September 21, 2021

Study Completion (Actual)

September 21, 2021

Study Registration Dates

First Submitted

March 7, 2018

First Submitted That Met QC Criteria

March 12, 2018

First Posted (Actual)

March 13, 2018

Study Record Updates

Last Update Posted (Actual)

September 14, 2023

Last Update Submitted That Met QC Criteria

September 13, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Volunteers

Clinical Trials on Sonar

Subscribe